<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02419547</url>
  </required_header>
  <id_info>
    <org_study_id>2013-P-000241</org_study_id>
    <nct_id>NCT02419547</nct_id>
  </id_info>
  <brief_title>Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia</brief_title>
  <official_title>Inducibility and Stability of Ventricular Tachycardia in Patients With Structural Heart Disease Undergoing VT Ablation Under General Anesthesia (Pilot Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is being done to see whether general anesthesia (GA) affects our ability
      to start ventricular tachycardia (VT) during an VT ablation procedure.

      Data collected during this research study will help electrophysiologists and
      anesthesiologists to make the best decisions about the best anesthetic conditions to use to
      perform VT ablations.

      This research study is a &quot;pilot&quot; study. Pilot studies are done on a small group of subjects
      to learn if a larger study would be useful.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inducibility of ventricular tachycardia intra-procedure</measure>
    <time_frame>Subjects will be followed for 3 months after the procedure</time_frame>
    <description>The primary outcome is the inducibility of ventricular tachycardia after induction of general anesthesia during the procedure.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Anesthesia Induction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients undergoing ventricular tachycardia ablation will undergo programmed stimulation (PS) with minimal sedation (Versed, Fentanyl), with intravenous agents (propofol) , and finally with volatile inhalational agent (sevoflurane).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Versed</intervention_name>
    <description>Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia</description>
    <arm_group_label>Anesthesia Induction</arm_group_label>
    <other_name>midazolam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia</description>
    <arm_group_label>Anesthesia Induction</arm_group_label>
    <other_name>Duragesic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Phase 2: Standard induction of GETA with intravenous agent then programed stimulation to induce ventricular tachycardia</description>
    <arm_group_label>Anesthesia Induction</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Phase 3: Standard induction of GETA with inhalent agent then programed stimulation to induce ventricular tachycardia</description>
    <arm_group_label>Anesthesia Induction</arm_group_label>
    <other_name>Ultane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with VT and have an implanted ICD who are scheduled for VT catheter ablation.

          -  Patients 18 years of age or older

        Exclusion Criteria:

          -  Patients with difficult airway management or patients with contra/ relative contra
             indication for general anesthesia or known allergies to any of the proposed anesthetic
             agents

          -  Women who are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendy L Gross, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alan D Enriquez, M.D.</last_name>
    <email>adenriquez@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine P Pellegrini, R.N.</last_name>
    <phone>617-732-5241</phone>
    <email>cpellegrini@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brigahm and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Wendy Gross, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>William G. Stevenson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2014</study_first_submitted>
  <study_first_submitted_qc>April 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2015</study_first_posted>
  <last_update_submitted>April 14, 2015</last_update_submitted>
  <last_update_submitted_qc>April 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Wendy Gross</investigator_full_name>
    <investigator_title>Vice Chair, Anesthesia for Interventional Medicine</investigator_title>
  </responsible_party>
  <keyword>Ventricular tachycardia</keyword>
  <keyword>ventricular tachycardia ablation</keyword>
  <keyword>effects of anesthesia on VT induction</keyword>
  <keyword>programed stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

